Bristol Myers Squibb CEO Chris Boerner sits down with CNBC's Angelica Peebles at the American Society of Clinical Oncology's ...

Summit said Harmoni-6 is the first Phase 3 study to show a "statistically significant" survival advantage over a PD-1 ...

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

View post: Anthony Head, Star of ‘Buffy the Vampire Slayer’ and ‘Ted Lasso,’ Dead at 72 The premise of Dutton Ranch is right there in the title: it’s a story about a new ranch for the Dutton family, ...

4 Reasons Pfizer Could Be a Value Play You Can't Miss BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to ...

Randall Colburn is a writer and editor at Entertainment Weekly. His work has previously appeared on The A.V. Club, The Guardian, The Ringer, and many other publications.

Add Yahoo as a preferred source to see more of our stories on Google. "It's been a big shift. Montana was the biggest character of [Yellowstone]," Reilly told USA Today. "So now we have a new ...

Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal year 2026. Daiichi Sankyo aims to be a global top-5 oncology player ...